Market Overview:
The global extracorporeal membrane oxygenation (ECMO) machine market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing incidence of respiratory and cardiac diseases, rising geriatric population, and technological advancements in ECMO machines. Based on type, the venoarterial (VA) segment is expected to account for the largest share of the global ECMO machine market in 2018. This segment is also projected to grow at a higher CAGR during the forecast period as compared to other segments. VA ECMO machines are used for both respiratory and cardiac applications. They are also considered as a last resort treatment option for patients with severe heart or lung failure who are not responding to other treatments such as mechanical ventilation or drugs therapy. Based on application, the respiratory segment is estimated to account for majority share of the global ECMO machine market in 2018 followed by cardiac and extracorporeal cardiopulmonary resuscitation (ECPR) segments respectively. The respiratory application dominates due high prevalence rate of various respiratory diseases such as chronic obstructive pulmonary disease (COPD), pneumonia, cystic fibrosis etc., across different geographies worldwide .
 Machine Industry Outlook.svg)
Product Definition:
The ECMO machine is a device that helps pump blood and oxygen to the body when the heart and lungs cannot do it alone. It is used as a last resort for people with life-threatening heart or lung conditions.
Venoarterial (VA):
Venoarterial ECMO (VA) is a technique of providing cardiopulmonary support to patients with cardiac and respiratory failure. It works by removing blood from the heart and lungs through a large vein, then oxygenated blood is pumped from the machine at high pressure. The process takes place in two steps- venous return and gas exchange.
Venovenous (VV):
Venovenous (VV) is a blood substitute which has the ability to replace the normal venous return blood flow without any adverse effects. The VV machine works by drawing blood from a patient and sending it back to the heart with an oxygenator.
Application Insights:
Based on the application, the global extra corporeal membrane oxygenation (ECMO) machine market is segmented into respiratory, cardiac and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment dominated the global market in terms of revenue in 2017. This can be attributed to factors such as high prevalence of respiratory disorders coupled with increasing awareness about ECMO machines. According to data published by ELSO, an estimated 585 million people suffer from chronic lung diseases worldwide; out of which 438 million are men and 128 million are women. Furthermore, according to WHO-UNOSAT collaboration for Improving Outpatient Services Data for Quality Improvement & Performance Measurement 2015-2016 Report Card: Key Findings, around 54% of patients suffering from acute lung injury go through full or partial recovery without any treatment; 29% receive only supportive care while 15% require ECMO therapy.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing healthcare expenditure, and rising incidence of respiratory failure. In addition, growing number of clinical studies on oxygen therapy is also expected to drive the demand for EVO machines in this region. For instance, according to FDA website there are more than 5000 product approvals from 1958 till date.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to improving healthcare infrastructure and rising awareness regarding advanced ECMO technologies such as Extracorporeal Membrane Oxygenation (ECMO) machine among physicians & surgeons especially in developing countries such as India & China. Moreover, increasing cases of cardiac arrest are also expected boost market growth during the forecast period. According with data published by WebMD Inc.
Growth Factors:
- Increasing incidence of respiratory diseases: The increasing incidence of respiratory diseases is one of the major growth drivers for the ECMO machine market. Respiratory diseases are caused due to various factors such as air pollution, smoking, and viral infections and are a leading cause of death worldwide. According to the World Health Organization (WHO), around 6 million people die each year due to respiratory problems. This is expected to create a high demand for ECMO machines in the coming years.
- Technological advancements: The technological advancements in ECMO machines are another major growth driver for this market. With continuous innovations, these machines have become more efficient and reliable, thus increasing their adoption rates across hospitals worldwide.
- Rising number of organ transplants: The rising number of organ transplants is also contributing significantly to the growth of the ECMO machine market globally. Organ transplant surgeries require prolonged support from an ECMO machine in order to reduce the risk associated with them and improve patient outcomes post-surgery Thus, owing to this growing demand, hospitals are increasingly investing in these machines thereby driving market growth further..
Scope Of The Report
Report Attributes
Report Details
Report Title
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Research Report
By Type
Venoarterial (VA), Venovenous (VV), Arteriovenous (AV)
By Application
Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)
By Companies
Getinge Group (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), EUROSETS S.r.l. (Italy)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Report Segments:
The global Extracorporeal Membrane Oxygenation (ECMO) Machine market is segmented on the basis of:
Types
Venoarterial (VA), Venovenous (VV), Arteriovenous (AV)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Getinge Group (Sweden)
- Medtronic plc (Ireland)
- LivaNova PLC (U.K.)
- XENIOS AG (Germany)
- Terumo Corporation (Japan)
- MicroPort Scientific Corporation (China)
- NIPRO Corporation (Japan)
- OriGen Biomedical, Inc. (U.S.)
- ALung Technologies, Inc. (Germany)
- EUROSETS S.r.l. (Italy)
 Machine Market Overview.svg)
Highlights of The Extracorporeal Membrane Oxygenation (ECMO) Machine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Venoarterial (VA)
- Venovenous (VV)
- Arteriovenous (AV)
- By Application:
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Extracorporeal Membrane Oxygenation (ECMO) Machine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Machine Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Extracorporeal Membrane Oxygenation (ECMO) machines are used to provide supplemental oxygen to patients with respiratory failure.
Some of the major companies in the extracorporeal membrane oxygenation (ecmo) machine market are Getinge Group (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), EUROSETS S.r.l. (Italy).
The extracorporeal membrane oxygenation (ecmo) machine market is expected to grow at a compound annual growth rate of 7.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Extracorporeal Membrane Oxygenation (ECMO) Machine Market - Supply Chain
4.5. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast
4.5.1. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Absolute $ Opportunity
5. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Type
5.3.1. Venoarterial (VA)
5.3.2. Venovenous (VV)
5.3.3. Arteriovenous (AV)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Application
6.3.1. Respiratory
6.3.2. Cardiac
6.3.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Demand Share Forecast, 2019-2026
9. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Application
9.4.1. Respiratory
9.4.2. Cardiac
9.4.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Type
9.7.1. Venoarterial (VA)
9.7.2. Venovenous (VV)
9.7.3. Arteriovenous (AV)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Demand Share Forecast, 2019-2026
10. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Application
10.4.1. Respiratory
10.4.2. Cardiac
10.4.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Type
10.7.1. Venoarterial (VA)
10.7.2. Venovenous (VV)
10.7.3. Arteriovenous (AV)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Demand Share Forecast, 2019-2026
11. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Application
11.4.1. Respiratory
11.4.2. Cardiac
11.4.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Extracorporeal Membrane Oxygenation (ECMO) Machin Market Size and Volume Forecast by Type
11.7.1. Venoarterial (VA)
11.7.2. Venovenous (VV)
11.7.3. Arteriovenous (AV)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Demand Share, 2019-2026
12. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Application
12.4.1. Respiratory
12.4.2. Cardiac
12.4.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Type
12.7.1. Venoarterial (VA)
12.7.2. Venovenous (VV)
12.7.3. Arteriovenous (AV)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Demand Share, 2019-2026
13. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Application
13.4.1. Respiratory
13.4.2. Cardiac
13.4.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size and Volume Forecast by Type
13.7.1. Venoarterial (VA)
13.7.2. Venovenous (VV)
13.7.3. Arteriovenous (AV)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market: Market Share Analysis
14.2. Extracorporeal Membrane Oxygenation (ECMO) Machine Distributors and Customers
14.3. Extracorporeal Membrane Oxygenation (ECMO) Machine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Getinge Group (Sweden)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic plc (Ireland)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LivaNova PLC (U.K.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. XENIOS AG (Germany)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Terumo Corporation (Japan)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MicroPort Scientific Corporation (China)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NIPRO Corporation (Japan)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. OriGen Biomedical, Inc. (U.S.)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ALung Technologies, Inc. (Germany)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. EUROSETS S.r.l. (Italy)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
